If marijuana were legal in the United States, most Americans say they would try it. And businesses are seeing green – potential profits – in all things cannabis, including in the Triangle.

The broad willingness to try marijuana is among the findings in a survey of 1,000 US consumers (as well as 1,000 more in Canada) conducted by A.T. Kearney, a global strategy and management consulting firm.

More than half of the survey’s respondents in both countries said they would likely try recreational cannabis if or when it becomes legal.

Marijuana will become legal in Canada on October 17. It remains illegal in the United States, although a number of states allow for its use.

Investor, corporate and entrepreneurial interest is already generating a cannabis ecosystem of sorts in the Triangle:

  • In Morrisville,  Pyxus — previously known as Alliance One International — announced on Oct. 2 that its subsidiary, GoldLeaf Pharm, received a license to cultivate medical cannabis in Canada. Its stock has soared nearly 40 percent recently.
  • In Raleigh, One Better Ventures, which is headed by former Burt’s Bees CEO John Replogle, is investing $2 million in Remedy Review, a new media company focused on “separating fact from fiction” in the growing market of cannabidiol (CBD), hemp-based products, and more.
  • And in Research Triangle Park, Root Bioscience, a startup focusing on marijuana/cannabis related products, has raised more than $2 million from investors.

The study comes at a time when many big brand name consumer companies are exploring a move into the legal cannabis business.

Morrisville firm’s stock rises 37 percent in craze for cannabis stock

Blue chip consumer companies simply see green in weed

Constellation Brands, the owner of Corona, has a more than $4 billion stake in cannabis company Canopy Growth (CGC).

During an earnings conference call with analysts last week, Constellation CEO Robert Sands said the decision to invest in the cannabis business was an “offensive move” as opposed to a defensive one.

Sands said Constellation originally got involved with Canopy to develop drinks but that as the deal progressed, “it became evident to us that the whole market, all channels, all forms, is going to be explosive.”

Raleigh startup focusing on cannabis-related product information lands $2M

Brewer Molson Coors is also getting into the cannabis market. It has a joint venture in Canada to develop non-alcoholic, cannabis-infused beverages.

Coca-Cola said last month that it is “closely watching” the cannabis sector as rumors swirled about it looking to partner with Canada’s Aurora Cannabis on a beverage that would have CBD, a non-psychoactive component in marijuana, as an ingredient.

And the chief financial officer of Pepsi recently said during an earnings conference call with analysts that it has looked into the cannabis industry, even though it has no current plans to get into the business while marijuana is still illegal in the US.

The beverage industry isn’t the only potential beneficiary.

Chapel Hill startup focusing on marijuana/cannabis products raises $970,000

According to the survey, 76% said they would use legal cannabis-infused products for therapeutic reasons.

Nearly a quarter indicated they’d try recreational cannabis via skincare products like lotions, creams and lip balms.

And 41% of the participants said they’d be more likely to try recreational cannabis through food, slightly higher than the 39% of those surveyed who said they would smoke it.

Randy Burt, a partner in the consumer goods and retail practice of A.T. Kearney, said the increased interest in cannabis on the part of big business makes sense considering the results of his firm’s survey.

Study: ‘Tasty’ cannabis edibles need better labels for safety

After all, nearly 40% of the participants said they would have an improved perception of a company if it were to become involved in the cannabis business.

“It seems like there would be little backlash if companies introduced products with CBD,” Burt said. “Consumer companies have to factor in the potential risk to their reputation and brand name but there may be less risk than once thought.”

“It could be very smart for consumer companies to be adding cannabis products to their portfolio,” Burt added. “It’s important to have a cannabis strategy.”